Antidepresivos de nueva generación en neuropatía diabética dolorosa [PDF]
Revista Ciencias de la Salud, 2011 The incidence of diabetic neuropathy increases with the duration of diabetes and the degree of hyperglycaemia. Pain is one of the mostcommon and incapacitating symptoms of diabetic neuropathy and itspharmacological control is complex.
Ángela M. Gutiérrez-Álvarez +1 more
doaj +1 more source
Hypertension and depression Hipertensão arterial sistêmica e depressão [PDF]
Clinics, 2005 Despite the high prevalence of depression and hypertension, the relationship between the two diseases has received little attention. This paper reviews the epidemiological, pathophysiological, and prognostic aspects of this association, as well as its ...
Andréia Zavaloni Scalco +3 more
doaj +2 more sources
Mirtazapine versus other antidepressive agents for depression. [PDF]
Cochrane Database Syst Rev, 2011 BACKGROUND: Mirtazapine has a unique mechanism of antidepressive action and is one of the commonly used antidepressants in clinical practice. OBJECTIVES: The aim of the present review was to assess the evidence on the efficacy and acceptability of ...
Watanabe N +6 more
europepmc +2 more sources
Sertraline versus other antidepressive agents for depression. [PDF]
Cochrane Database Syst Rev, 2010 BACKGROUND: The National Institute for Health and Clinical Excellence clinical practice guideline on the treatment of depressive disorder recommended that selective serotonin reuptake inhibitors should be the first-line option when drug therapy is ...
Cipriani A +7 more
europepmc +4 more sources
Milnacipran versus other antidepressive agents for depression. [PDF]
Cochrane Database Syst Rev, 2009 BACKGROUND: Although pharmacological and psychological interventions are both effective for major depression, antidepressant drugs are frequently used as first-line treatment in primary and secondary care settings.
Nakagawa A +7 more
europepmc +2 more sources
Advancing Antidepressive Agents: Drug Discovery and Polymer-Based Drug Delivery Systems for Improved Treatment Outcome. [PDF]
BiomedicinesDepressive disorder (a subclass of mental disorders) is characterized by persistent affective symptoms. Without timely therapeutic intervention, it leads to clinical deterioration manifested as reduced quality of life and may increase suicide risk in ...
Zhang Y +7 more
europepmc +2 more sources
Depression clinical trials worldwide: a systematic analysis of the ICTRP and comparison with ClinicalTrials.gov [PDF]
Translational PsychiatryMajor depressive disorder (MDD), commonly known as depression, affects over 300 million people worldwide as of 2018 and presents a wide range of clinical symptoms.
Eugenia D. Namiot +5 more
doaj +2 more sources
Los placebos, el dolor neuropàtico y de género
Acta Neurológica Colombiana, 2023 INTRODUCTION: the placebos' analgesic effect seems to depend on different factors such as socio-cultural, psychological and genetic aspects. The effects of gender on placebos' analgesic response have rarely been documented in clinical studies, even ...
Carlos B. Moreno +1 more
doaj +2 more sources
Reboxetine versus other antidepressive agents for depression [PDF]
, 2009 Reboxetine versus other antidepressive agents for ...
CIPRIANI, Andrea +7 more
core +1 more source
Severe hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with fluoxetine: case report [PDF]
Arquivos de Neuro-Psiquiatria, 2006 Hyponatremia is a significant complication of treatment with serotonin selective reuptake inhibitors (SSRI). We describe a case of a 53-year-old woman that was started on fluoxetine 20 mg/day for depression.
Carlos Alexandre Twardowschy +3 more
doaj +1 more source